{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Cingulate Inc."},"Symbol":{"label":"Symbol","value":"CING"},"Address":{"label":"Address","value":"1901 W. 47TH PLACE, KANSAS, Kansas, 66205, United States"},"Phone":{"label":"Phone","value":"+1 913 942-2300"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes."},"CompanyUrl":{"label":"Company Url","value":"https://www.cingulate.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Laurie A. Myers","title":"Chief Operating Officer & Executive VP"},{"name":"Matthew N. Brams","title":"Chief Medical Officer & Executive Vice President"},{"name":"Raul R. Silva","title":"Chief Science Officer & Executive VP"},{"name":"Shane J. Schaffer","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}